Hardide PLC (HDD)

ORD 4P

Sell: 32.00p|Buy: 36.00p|Change: 0 (0%)

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

AIM WINNERS & LOSERS: Hardide wins contract; Trellus Health falls

AIM WINNERS & LOSERS: Hardide wins contract; Trellus Health falls 2026-02-03T11:16:41+0000

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

----------

AIM - WINNERS

----------

Hardide PLC, up 27% at 20.36 pence, 12-month range 21.70p-5.00p. The provider of advanced surface coating technology says it won a follow-on order from a customer in North America worth USD1.0 million. As a result, it expects its financial performance for financial 2026 to be ahead of previous expectations.

----------

Xtract Resources PLC, up 25% at 1.00p, 12-month range 1.30p-0.40p. The Australia and Zambia-focused miner agrees to enter new joint venture for development of copper mining operations at the Zambia mining licence. It strikes the joint venture with the holder of the licence, Oval Mining, and Cooperlemon Consultancy. "We are pleased to have concluded this small scale copper mining agreement with Oval with respect to the Mining licence. With the continued partnership of Cooperlemon, the parties will be seeking to exploit the high grade material identified in the breccia pipe and surrounding areas," says Executive Chair Colin Bird.

----------

AIM - LOSERS

----------

Trellus Health PLC, down 26% at 0.70p, 12-month range 3.10p-0.32p. The healthcare company expects 2025 revenue to be USD545,000. The firm reduces its monthly cash burn to around USD400,000, which was "moderately offset" by recurring monthly management fees during the second half of the year. The firm says it remains in ongoing discussions to find alternative sources of funding to further extend its cash runway, which currently runs to late in the first quarter. "We continue to manage costs and working capital carefully and are encouraged by the growing validation of our differentiated, behavioural science-based approach. We remain focused on progressing commercial discussions and look forward to updating the market on further developments," says Chief Executive Officer Marla Dubinsky.

----------

By Michael Hennessey, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.